Literature DB >> 7865953

Initiation of a fibrinolytic system in hepatic resection: the roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1.

M Shimada1, T Matsumata, K Yamamoto, H Itasaka, A Taketomi, K Sugimachi.   

Abstract

The factors related to the initiation of fibrinolysis, especially with regard to the tissue-type plasminogen activator (tPA) and the plasminogen activator inhibitor-1 (PAI-1), were investigated in 15 patients who underwent hepatic resection, and the findings were compared between those with normal livers and those with diseased livers. It was found that tPA increased before hepatic division, whereas PAI-1 increased after hepatic division and reached a peak immediately following the operation. Plasminogen decreased during hepatectomy, reaching its lowest point on postoperative day 1, and increasing later. Decreased levels of both plasminogen and the alpha 2-plasmin inhibitor were considered to be partly due to plasmin formation in the blood. Patients with a diseased liver tended to have higher intraoperative values of euglobulin lysis activity and higher postoperative values of plasminogen activator, but significantly lower postoperative values of alpha 2-plasmin inhibitor than those with a normal liver. The results of this study suggest that activation of the fibrinolytic system occurs both during hepatectomy and in the early postoperative period, and that patients with a diseased liver are prone to develop hyperfibrinolysis during hepatectomy. Moreover, the increased levels of both tPA and PAI-1 can serve as one of the most sensitive markers for the vital reaction against surgical stress.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865953     DOI: 10.1007/bf01636306

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Inhibition by aprotinin of tPA-mediated fibrinolysis during orthotopic liver transplantation.

Authors:  B J Hunt; S Cottam; H Segal; R Ginsburg; D Potter
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

2.  The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.

Authors:  H Grosse; W Lobbes; M Frambach; O von Broen; B Ringe; M Barthels
Journal:  Thromb Res       Date:  1991-08-01       Impact factor: 3.944

3.  Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.

Authors:  J Kambayashi; M Sakon; M Yokota; E Shiba; T Kawasaki; T Mori
Journal:  Thromb Res       Date:  1990-10-15       Impact factor: 3.944

Review 4.  Type 1 plasminogen activator inhibitor.

Authors:  D J Loskutoff; M Sawdey; J Mimuro
Journal:  Prog Hemost Thromb       Date:  1989

5.  Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.

Authors:  N A Booth; J A Anderson; B Bennett
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

6.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

Authors:  T Ny; F Elgh; B Lund
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

Authors:  E G Levin; U Marzec; J Anderson; L A Harker
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Tissue plasminogen activator release in vivo in response to vasoactive agents.

Authors:  D Smith; M Gilbert; W G Owen
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

10.  Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.

Authors:  E J Brommer; F H Derkx; M A Schalekamp; G Dooijewaard; M M vd Klaauw
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

View more
  1 in total

1.  The role of serum interleukin-8 in hepatic resections.

Authors:  Tomonobu Gion; Akinobu Taketomi; Ken Shirabe; Hirofumi Hasegawa; Takayuki Hamatsu; Yo-Ichi Yamashita; Keishi Sugimachi; Tomoharu Yoshizumi; Yuji Soejima; Mitsuo Shimada; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.